颜建周
Personal Homepage
Paper Publications
Degarelix vs. leuprorelin for the treatment of prostate cancer in China: A cost-utility analysis. 2022.7;10:942800.
Hits:
Personal information

Associate Professor

Date of Birth:1986-10-06

E-Mail:

Date of Employment:2012-07-01

School/Department:药事法规教研室

Gender:Male

Degree:Doctoral Degree in Science

Status:在岗

Alma Mater:中国药科大学

You are visitors

The Last Update Time : ..


© 2015 China  Pharmaceutical  University

MOBILE Version